All Pathways
NephrologyEmergency

Urgent Dialysis Indications (KDIGO)

Urgent Dialysis Indications (KDIGO): AKI or ESRD with Complications → Life-Threatening Indication? → EMERGENT DIALYSIS → Choose RRT Modality → Intermitt...

Pathway Overview

16 steps

Algorithm Steps

16 total

  1. 01Start

    AKI or ESRD with Complications

    Consider need for renal replacement therapy

  2. 02Decision

    Life-Threatening Indication?

    Absolute indications for urgent RRT (AEIOU)

    • A - Acidosis: pH <7.1 refractory to bicarb
    • E - Electrolytes: Hyperkalemia K+ >6.5 refractory to medical Rx
    • I - Intoxication: Dialyzable toxin (lithium, methanol, ethylene glycol, salicylate)
    • O - Overload: Pulmonary edema refractory to diuretics
    • U - Uremia: Encephalopathy, pericarditis, bleeding
  3. 03Warning

    EMERGENT DIALYSIS

    Life-threatening - initiate RRT immediately

    • Nephrology STAT consult
    • Vascular access (temporary catheter if no access)
    • ICU admission if not already
    • HD preferred if hemodynamically stable
    • CRRT if hemodynamically unstable
  4. 04Decision

    Choose RRT Modality

    HD vs CRRT

    • HD: Hemodynamically stable, need rapid correction
    • CRRT: Hemodynamically unstable, cerebral edema risk, slower correction needed
    • SLED: Hybrid approach
  5. 05Action

    Intermittent HD

    Standard hemodialysis

    • Duration: 3-4 hours
    • Faster solute clearance
    • Better for severe hyperkalemia, toxins
    • Requires hemodynamic stability
  6. 06Outcome

    RRT Initiated

    Monitor for recovery, reassess daily

  7. 07Action

    CRRT

    Continuous renal replacement therapy

    • CVVH, CVVHD, or CVVHDF
    • Better hemodynamic tolerance
    • Slower solute clearance
    • ICU setting required
    • Anticoagulation considerations
  8. Path rejoins step 06Shared downstream outcome
  9. 08Action

    Severe Metabolic Acidosis

    pH <7.1 or HCO3 <10 mEq/L

    • Trial of IV sodium bicarbonate first
    • If refractory or volume overloaded → RRT
    • HD superior for rapid correction
    • Bicarbonate-based dialysate
  10. Path rejoins step 03Shared downstream outcome
  11. 09Action

    Refractory Hyperkalemia

    K+ >6.5 mEq/L despite medical therapy

    • Medical therapy: Calcium, insulin/glucose, albuterol, K+ binders
    • If ECG changes persist or K+ not controlled → RRT
    • HD removes 25-50 mEq K+/hour
    • Watch for rebound post-dialysis
  12. Path rejoins step 03Shared downstream outcome
  13. 10Action

    Dialyzable Toxin

    Severe poisoning with dialyzable substance

    • Classic SLIME: Salicylates, Lithium, Isopropanol, Methanol, Ethylene glycol
    • Also: Metformin (severe lactic acidosis), valproic acid
    • Poison control consultation
    • Prolonged/high-flux HD may be needed
  14. Path rejoins step 03Shared downstream outcome
  15. 11Action

    Refractory Volume Overload

    Pulmonary edema not responding to diuretics

    • High-dose IV diuretics first (furosemide up to 200-400mg)
    • Diuretic resistance: CrCl <20, nephrotic syndrome
    • If O2 requirement increasing despite diuretics → RRT
    • Ultrafiltration or HD with UF
  16. Path rejoins step 03Shared downstream outcome
  17. 12Action

    Uremic Complications

    End-organ manifestations of uremia

    • Encephalopathy: Asterixis, confusion, somnolence
    • Pericarditis: Friction rub, chest pain (avoid anticoag)
    • Uremic bleeding: Platelet dysfunction
    • Nausea/vomiting: Intractable
    • Any uremic complication → strong indication for RRT
  18. Path rejoins step 03Shared downstream outcome
  19. 13Decision

    Relative Indications?

    Non-emergent but may benefit from RRT

    • Oliguria >72h despite optimization
    • Progressive azotemia without improvement
    • Nutrition: Cannot provide adequate nutrition due to fluid
    • Drug clearance: Need to clear drug for dosing
  20. 14Action

    Continue Supportive Care

    Optimize without RRT, monitor closely

    • Optimize volume status and hemodynamics
    • Avoid nephrotoxins
    • Adjust medication dosing
    • Daily labs, strict I/O
    • Nephrology follow-up
  21. 15Outcome

    Renal Recovery

    Continue monitoring, avoid future nephrotoxins

  22. 16Action

    Plan RRT Initiation

    Non-emergent but RRT indicated

    • Discuss with nephrology
    • Consider vascular access planning
    • Patient/family discussion
    • Choose modality (HD vs CRRT vs PD)
  23. Path rejoins step 04Shared downstream outcome

Guideline Source

KDIGO Clinical Practice Guideline for Acute Kidney Injury

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not address dialysis modality selection in detail
  • Timing of non-emergent RRT initiation controversial
  • Simplified criteria - clinical judgment essential
  • Does not cover peritoneal dialysis initiation

Applicable Regions

EUUSglobal

global: KDIGO criteria widely accepted; local practice may vary

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Urgent Dialysis Indications (KDIGO)?

The Urgent Dialysis Indications (KDIGO) is a emergency clinical algorithm for Nephrology. It provides a structured decision tree to guide clinical decision-making, based on KDIGO Clinical Practice Guideline for Acute Kidney Injury.

What guideline is the Urgent Dialysis Indications (KDIGO) based on?

This algorithm is based on KDIGO Clinical Practice Guideline for Acute Kidney Injury (DOI: 10.1159/000339789).

What are the limitations of the Urgent Dialysis Indications (KDIGO)?

Known limitations include: Does not address dialysis modality selection in detail; Timing of non-emergent RRT initiation controversial; Simplified criteria - clinical judgment essential; Does not cover peritoneal dialysis initiation. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Urgent Dialysis Indications (KDIGO) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free